Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference
September 06 2018 - 8:00AM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that
Patrick J. Mahaffy, Chief Executive Officer and President, will
present at the 16th Annual Morgan Stanley Global Healthcare
Conference on Thursday, September 13, 2018 at 2:55 PM Eastern Time.
The conference will be held at the Grand Hyatt New York in New York
City.
A live webcast of the presentation can be accessed through the
investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay
of the webcast will be available on the Company’s website for 30
days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools that direct a compound in development to the
population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado, and has additional
offices in San Francisco, California and Cambridge, UK. Please
visit www.clovisoncology.com for more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180906005129/en/
Clovis OncologyAnna Sussman,
303-625-5022asussman@clovisoncology.comotBreanna Burkart,
303-625-5023bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024